Serjania marginata Casar. Hydroalcoholic Extract Reduced Cytokine and Inflammatory Parameters in Experimental Models of Inflammation and Infection in Mice

Maicon Matos Leitão; Joyce Alencar Santos Radai; Luis Fernando Benitez Macorini; Thiago Leite Fraga; Silvia Cristina Heredia-Viira; Claudia Andrea Lima Cardoso; Arielle Cristina Arena; Candida Aparecida Leite Kassuya

Serjania marginata Casar. Hydroalcoholic Extract Reduced Cytokine and Inflammatory Parameters in Experimental Models of Inflammation and Infection in Mice

Articles

Abstract

Pharmacognosy Research,2022,14,2,127-134.

DOI:10.5530/pres.14.2.18

Published:April 2022

Type:Original Article

Authors:

Author(s) affiliations:

Maicon Matos Leitão^1,2,*, Joyce Alencar Santos Radai¹, Luis Fernando Benitez Macorini¹, Thiago Leite Fraga¹, Silvia Cristina Heredia-Vieira³, Claudia Andrea Lima Cardoso⁴, Arielle Cristina Arena⁵, Candida Aparecida Leite Kassuya¹

¹School of Health Sciences, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul State, BRAZIL.

²School of Health Sciences, Unigran Capital University Center, Campo Grande, Mato Grosso do Sul State, BRAZIL.

³Center of Health Sciences, Anhanguera- Uniderp University, Campo Grande, Mato Grosso do Sul State, BRAZIL.

⁴Center of Studies on Natural Resources, Mato Grosso do Sul State University, Dourados, Mato Grosso do Sul State, BRAZIL.

⁵Department of Morphology, Institute of Biosciences of Botucatu, Paulista State University, Botucatu, SP, BRAZIL.

Abstract:

Objectives: This study investigated the antimycobacterial, anti-inflammatory and antihyperalgesic effects of hydroalcoholic extract from leaves of S. marginata (EESM) in in vitro and in vivo models. Methods and Results: EESM (0.98–1000 μg/ml) was evaluated in in vitro against Mycobacterium tuberculosis, M. bovis, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus epidermidis. The EESM oral administration (p.o.) (30, 100 and 300 mg/kg) and dexamethasone subcutaneous injection (s.c.) (1 mg/kg) were tested against the carrageenan-induced inflammatory paw edema and pleurisy in Swiss mice. The EESM (30 and 100 mg/kg, p.o.) and dexamethasone (1 mg/kg, s.c.) were tested against the CFA-induced paw inflammation and M. bovis (bacillus Calmette-Guerin - BCG)-induced pleurisy in C57bL6 mice. The minimum inhibitory concentration (MIC) of EESM in the presence of M. tuberculosis was 62.4 μg/ml. The values of MIC of EESM in the presence S. epidermidis, K. pneumoniae were 1000 μg/mL while EESM did not interfere against P. aeruginosa growth. EESM significantly inhibited paw edema/mechanical hyperalgesia in carrageenan induced paw inflammation and leukocytes migration/proteins exudation in carrageenan-induced pleurisy model. In the BCGinduced pleurisy model, the daily treatment for 7 days, with EESM inhibited the levels of IL-1β in blood and in pleural exudate. The EESM did not alter the mycobacterial growth in the cell culture from pleural lavage, spleen and liver samples collected from BCG-treated animals. The EESM significantly inhibited the persistent edema and mechanical hyperalgesia induced by CFA. Conclusion: This study confirms the EESM anti-inflammatory property and showed that EESM has high potency in inducing inhibition of mycobaterial growth and low potency or no effects in relation to other microorganisms.

Key words: Mycobacterium tuberculosis, Bacillus Calmette-Guerin (BCG), Cipó-timbó, Inflammation, Tuberculosis.